Oct. 24 at 4:42 PM
$SLS $CPXX was a great Illustration of what will be happening here.
it was a Puny
$50M mcap
$1.68 when it released its AML Phase 3 Trial Results.
It Gapped up to
$250M +500% that Day, kept climbing to to
$750M mcap
and then got bought for
$1.5B +1,600% in 2 months, based on P3 trial results, that told the whole market and
$JAZZ that it was for sure getting FDA Approval and going to generate REAL REVENUE.
Ps... SLS009 is a direct head to head competitive treatment in the AML-MR segment.
You can See CPXX was approved w 9.59 months of OS in FRONT LINE / NEWLY dxd AML-MR patients - SLS009 p2 OS of 9 months in END STAGE AML-MR.
Just 009 is worth worth 10x the current market cap. and the P3 is fully funded SLS has
$68M in Cash /
$6.7M q Burn / runway into 2027 - no Offerings needed /Allowed per S3 through Jan.
